In an article called, “Trump coaxes big promises from big pharma,” Jane is quoted on the recent announcements from pharma companies who are reducing certain prescription drug prices through the end of 2018. ‘This is not a policy, this is self-regulation – these are ad hoc agreements that are verbal and can change,’ Jane explained. Check out the in-depth analysis by Rebecca Trager.
Jane quoted in Royal Society of Chemistry journal on President Trump’s prescription drug pricing policy
By Jane Sarasohn-Kahn on 25 July 2018 in
News and Upcoming Events
I'm in amazing company here with other #digitalhealth innovators, thinkers and doers. Thank you to Cristian Cortez Fernandez and Zallud for this recognition; I'm grateful.
Jane was named as a member of the AHIP 2024 Advisory Board, joining some valued colleagues to prepare for the challenges and opportunities facing health plans, systems, and other industry stakeholders. Looking forward to AHIP 2024 in Las Vegas come June 11-13, 2024.
Join Jane at AHIP's annual meeting in Las Vegas: I'll be speaking, moderating a panel, and providing thought leadership on health consumers and bolstering equity, empowerment, and self-care.
RSS Feed
SUBSCRIBE TO BLOG UPDATES
About
Founded in 2007, the Health Populi website has over 2,000 posts, along with a library of Jane's writings and media mentions. Please use our search and filter functions to find the relevant posts for you. Make sure to sign up to our RSS feeds and join us on Twitter, too, by following @HealthyThinker.
Jane Sarasohn-Kahn, MA, MHSA